Garczorz W - Search Results

1

Antidiabetic Drugs in Breast Cancer Patients.

Garczorz W, Kosowska A, Francuz T. Garczorz W, et al. Cancers (Basel). 2024 Jan 10;16(2):299. doi: 10.3390/cancers16020299. Cancers (Basel). 2024. PMID: 38254789 Free PMC article. Review.

2

The Influence of Anti-Diabetic Drugs on Prostate Cancer.

Knura M, Garczorz W, Borek A, Drzymała F, Rachwał K, George K, Francuz T. Knura M, et al. Among authors: garczorz w. Cancers (Basel). 2021 Apr 12;13(8):1827. doi: 10.3390/cancers13081827. Cancers (Basel). 2021. PMID: 33921222 Free PMC article. Review.

3

SGLT-2 Inhibitors in Cancer Treatment-Mechanisms of Action and Emerging New Perspectives.

Dutka M, Bobiński R, Francuz T, Garczorz W, Zimmer K, Ilczak T, Ćwiertnia M, Hajduga MB. Dutka M, et al. Among authors: garczorz w. Cancers (Basel). 2022 Nov 25;14(23):5811. doi: 10.3390/cancers14235811. Cancers (Basel). 2022. PMID: 36497303 Free PMC article. Review.

4

Exenatide modulates tumor-endothelial cell interactions in human ovarian cancer cells.

Kosowska A, Gallego-Colon E, Garczorz W, Kłych-Ratuszny A, Aghdam MRF, Woz Niak M, Witek A, Wróblewska-Czech A, Cygal A, Wojnar J, Francuz T. Kosowska A, et al. Among authors: garczorz w. Endocr Connect. 2017 Nov;6(8):856-865. doi: 10.1530/EC-17-0294. Epub 2017 Oct 17. Endocr Connect. 2017. PMID: 29042458 Free PMC article.

5

Exenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activation.

Garczorz W, Gallego-Colon E, Kosowska A, Kłych-Ratuszny A, Woźniak M, Marcol W, Niesner KJ, Francuz T. Garczorz W, et al. Cardiovasc Ther. 2018 Apr;36(2). doi: 10.1111/1755-5922.12317. Epub 2018 Jan 24. Cardiovasc Ther. 2018. PMID: 29283509 Free article.

6

Exenatide modulates metalloproteinase expression in human cardiac smooth muscle cells via the inhibition of Akt signaling pathway.

Gallego-Colon E, Klych-Ratuszny A, Kosowska A, Garczorz W, Aghdam MRF, Wozniak M, Francuz T. Gallego-Colon E, et al. Among authors: garczorz w. Pharmacol Rep. 2018 Feb;70(1):178-183. doi: 10.1016/j.pharep.2017.10.003. Epub 2017 Oct 4. Pharmacol Rep. 2018. PMID: 29414148

7

Sitagliptin Modulates the Response of Ovarian Cancer Cells to Chemotherapeutic Agents.

Kosowska A, Garczorz W, Kłych-Ratuszny A, Aghdam MRF, Kimsa-Furdzik M, Simka-Lampa K, Francuz T. Kosowska A, et al. Among authors: garczorz w. Int J Mol Sci. 2020 Nov 26;21(23):8976. doi: 10.3390/ijms21238976. Int J Mol Sci. 2020. PMID: 33256016 Free PMC article.

8

The influence of elastin degradation products, glucose and atorvastatin on metalloproteinase-1, -2, -9 and tissue inhibitor of metalloproteinases-1, -2, -3 expression in human retinal pigment epithelial cells.

Dorecka M, Francuz T, Garczorz W, Siemianowicz K, Romaniuk W. Dorecka M, et al. Among authors: garczorz w. Acta Biochim Pol. 2014;61(2):265-70. Epub 2014 Jun 6. Acta Biochim Pol. 2014. PMID: 24904926 Free article.

9

Effects of incretin agonists on endothelial nitric oxide synthase expression and nitric oxide synthesis in human coronary artery endothelial cells exposed to TNFα and glycated albumin.

Garczorz W, Francuz T, Siemianowicz K, Kosowska A, Kłych A, Aghdam MR, Jagoda K. Garczorz W, et al. Pharmacol Rep. 2015 Feb;67(1):69-77. doi: 10.1016/j.pharep.2014.08.007. Epub 2014 Aug 23. Pharmacol Rep. 2015. PMID: 25560578

10

Effect of elastin-derived peptides on the production of tissue inhibitor of metalloproteinase-1, -2, and -3 and the ratios in various endothelial cell lines.

Siemianowicz K, Likus W, Francuz T, Garczorz W. Siemianowicz K, et al. Among authors: garczorz w. Exp Ther Med. 2015 Jun;9(6):2245-2250. doi: 10.3892/etm.2015.2429. Epub 2015 Apr 17. Exp Ther Med. 2015. PMID: 26136968 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page